Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2026-02-28 @ 3:30 AM
Study NCT ID:
NCT02023593
Status:
COMPLETED
Last Update Posted:
2023-02-16
First Post:
2013-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma
Sponsor:
Yuhong Li
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FOLFIRI-29
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None